SEC Form 4 · accession 0001104659-17-000983
Voyager Therapeutics, Inc. · VYGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wendy L Dixon
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640266
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.97 | Jan 3, 2017 | A | 30,000 | A | — | Jan 3, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1These stock options were issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan. The shares of common stock underlying the options will vest in quarterly installments subject to continued service.